Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $602.25 | 1 | 87.5% |
| Food and Beverage | $86.39 | 4 | 12.5% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Physician Discoveries, LLC | $602.25 | 2 | $0 (2017) |
| Intuitive Surgical, Inc. | $30.06 | 1 | $0 (2017) |
| Neomend, Inc. | $27.74 | 1 | $0 (2017) |
| TOLMAR Pharmaceuticals, Inc. | $16.57 | 1 | $0 (2020) |
| Mallinckrodt LLC | $12.02 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $16.57 | 1 | TOLMAR Pharmaceuticals, Inc. ($16.57) |
| 2017 | $672.07 | 5 | Physician Discoveries, LLC ($602.25) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/18/2020 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Prostate Cancer | ||||||
| 07/29/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: ACUTE CARE | ||||||
| 03/07/2017 | Physician Discoveries, LLC | — | Current or prospective ownership or investment interest | Stock | $602.25 | General |
| 02/02/2017 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: SURGERY | ||||||
| 01/18/2017 | Neomend, Inc. | DAV-Arista AH (Device) | Food and Beverage | Cash or cash equivalent | $27.74 | General |
| Category: Surgical | ||||||
| 2017 | Physician Discoveries, LLC | — | — | — | $0.00 | Ownership |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,873 | 2,233 | $398,138 | $148,827 |
| 2022 | 19 | 1,461 | 1,689 | $281,517 | $104,126 |
| 2021 | 18 | 1,229 | 1,586 | $265,520 | $113,410 |
| 2020 | 16 | 1,180 | 1,473 | $144,200 | $83,033 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 498 | 573 | $140,385 | $48,092 | 34.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 29 | 198 | $55,077 | $27,321 | 49.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 189 | 211 | $39,035 | $12,494 | 32.0% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 14 | 14 | $20,062 | $7,898 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 110 | $19,030 | $6,909 | 36.3% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 20 | 22 | $17,732 | $6,861 | 38.7% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 14 | 15 | $15,000 | $6,567 | 43.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 94 | 94 | $19,834 | $6,309 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 35 | $12,005 | $4,566 | 38.0% |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | Facility | 2023 | 12 | 12 | $9,120 | $3,463 | 38.0% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 13 | 13 | $7,293 | $2,595 | 35.6% |
| 52351 | Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope | Facility | 2023 | 11 | 11 | $6,457 | $2,186 | 33.9% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 23 | 23 | $5,842 | $2,103 | 36.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 16 | 17 | $5,490 | $1,757 | 32.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 191 | 217 | $6,293 | $1,658 | 26.3% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 64 | 66 | $4,026 | $1,371 | 34.0% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 61 | 68 | $3,332 | $1,291 | 38.7% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 15 | 35 | $1,750 | $1,226 | 70.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 29 | 34 | $2,448 | $909.16 | 37.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 14 | $1,918 | $867.30 | 45.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 117 | 123 | $738.00 | $718.54 | 97.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 261 | 278 | $1,390 | $609.64 | 43.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 23 | 23 | $1,472 | $556.16 | 37.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $1,284 | $355.76 | 27.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 14 | 15 | $1,125 | $144.30 | 12.8% |
About Dr. Christopher Stands, MD
Dr. Christopher Stands, MD is a Urology healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1023228483.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Stands, MD has received a total of $688.64 in payments from pharmaceutical and medical device companies, with $16.57 received in 2020. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($602.25).
As a Medicare-enrolled provider, Stands has provided services to 5,743 Medicare beneficiaries, totaling 6,981 services with total Medicare billing of $449,396. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Lynchburg, VA
- Active Since 05/23/2007
- Last Updated 02/05/2009
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1023228483
Products in Payments
- Da Vinci Surgical System (Device) $30.06
- DAV-Arista AH (Device) $27.74
- ELIGARD (Drug) $16.57
- OFIRMEV (Drug) $12.02
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Lynchburg
Ronald Fisher, M.d, M.D
Urology — Payments: $1,029
Dr. Corey Passman, Md, MD
Urology — Payments: $920.39
Robert Cook, M.d, M.D
Urology — Payments: $741.78
David Leffke, M.d, M.D
Urology — Payments: $602.25
Dr. Steven Koziol, M.d, M.D
Urology — Payments: $513.96